Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2015 1
2016 2
2018 1
2019 3
2020 7
2021 5
2022 12
2023 2
2024 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group.
Berenguer-Ruiz S, Aparicio-Domínguez M, Herranz-Pinto P, Ruíz-Villaverde R, López-Ferrer A, Santos-Juanes J, Rodríguez Fernández-Freire L, Hospital-Gil M, Arias-Santiago S, Carretero-Hernández G, Mateu-Puchades A, Ferran M, Del Alcázar E, Santos-Alarcón S, Garcia-Latasa de Aranibar FJ, Belinchón-Romero I, González-Cantero Á, Ruíz-Genao D, Eiris-Salvado N, Rocamora-Durán V, Rivera-Diaz R, de la Cueva P, Daudén E, Salgado-Boquete L, Llamas-Velasco M; Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Berenguer-Ruiz S, et al. Among authors: rodriguez fernandez freire l. J Eur Acad Dermatol Venereol. 2023 Dec;37(12):2517-2525. doi: 10.1111/jdv.19468. Epub 2023 Sep 1. J Eur Acad Dermatol Venereol. 2023. PMID: 37625815
A Non-Interventional, Multicenter Study to Characterize the Socio-Demographics, Clinical Characteristics, and Management of Generalized Pustular Psoriasis Patients in Spain: IMPULSE Study.
Puig L, Izu Belloso R, Rivera-Díaz R, Mollet Sánchez J, Rodríguez Fernández-Freire L, Sahuquillo-Torralba A, Ruiz-Villaverde R; IMPULSE investigators group. Puig L, et al. Among authors: rodriguez fernandez freire l. Dermatology. 2024;240(5-6):778-792. doi: 10.1159/000540019. Epub 2024 Jul 17. Dermatology. 2024. PMID: 39019021 Free PMC article.
Tildrakizumab: short-term efficacy and safety in real clinical practice.
Galán-Gutierrez M, Rodriguez-Fernandez Freire L, Ruiz-Villaverde R. Galán-Gutierrez M, et al. Among authors: rodriguez fernandez freire l. Int J Dermatol. 2022 Sep;61(9):e355-e357. doi: 10.1111/ijd.15840. Epub 2021 Oct 11. Int J Dermatol. 2022. PMID: 34632570 No abstract available.
Guselkumab: Short-term effectiveness and safety in real clinical practice.
Rodriguez Fernandez-Freire L, Galán-Gutierrez M, Armario-Hita JC, Perez-Gil A, Ruiz-Villaverde R. Rodriguez Fernandez-Freire L, et al. Dermatol Ther. 2020 May;33(3):e13344. doi: 10.1111/dth.13344. Epub 2020 Apr 20. Dermatol Ther. 2020. PMID: 32227659 No abstract available.
29 results